Australian Clinical Labs Ltd (AU:ACL) has released an update.
First Sentier Investors Holdings Pty Limited, along with its associates, has emerged as a substantial holder in Australian Clinical Labs Ltd, wielding voting power over 10,109,010 fully paid ordinary shares. This position was established on April 17, 2024, under the provisions of the Corporations Act 2001, which grants them the ability to control both voting rights and disposal of these shares. Behind this substantial stake lies the ultimate parent company, Mitsubishi UFJ Financial Group, Inc., which also holds relevant interests.
For further insights into AU:ACL stock, check out TipRanks’ Stock Analysis page.
